Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women.

American journal of reproductive immunology (New York, N.Y. : 1989) - 1 Jul 2013

Subrt Ivan, Ulcova-Gallova Zdenka, Cerna Monika, Hejnalova Marketa, Slovanova Jitka, Bibkova Katarina, Micanova Zdenka

Abstract excerpt

PROBLEM: This study compares the frequencies of plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and its relationship with eight antiphospholipid antibodies (aPLs) in serum of 157 patients with repeated pregnancy loss (RPL). METHOD OF STUDY: PAI-1 (-675) 4G/5G polymorphism was determined using standard PCR-RFLP method. Enzyme-linked immunosorbent assay was used for the detection of aPLs against...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abortion, Habitual
Share to Antibodies, Antiphospholipid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Czech Republic

Share to Gene Frequency

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Pregnancy

Share to White People

Source

Identifiers

PMID: 23445116
DOI: 10.1111/aji.12099

Genes

GPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in Czech women.PMID 23445116Read ↗

Recurrent pregnancy loss and frequency of eight antiphospholipid antibodies and genetic thrombophilic factors in Czech women.Semantic proximity Read ↗

Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.Semantic proximity Read ↗

Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.Semantic proximity Read ↗

The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.Semantic proximity Read ↗

[Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].Semantic proximity Read ↗

Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.Semantic proximity Read ↗

Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.Semantic proximity Read ↗

Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 4G/5G gene polymorphism in women with fetal loss.Semantic proximity Read ↗

[Implication of PAI-1 4G/5G polymorphism in recurrent implantation failure after IVF].Semantic proximity Read ↗

Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations.Semantic proximity Read ↗

Hereditary thrombophilia, anti-beta2 glycoprotein 1 IgM, and anti-annexin V antibodies in recurrent pregnancy loss.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.